πŸ‡ΊπŸ‡Έ FDA
Patent

US 7598277

Inhibitors of p38

granted A61PA61P1/02A61P1/04

Quick answer

US patent 7598277 (Inhibitors of p38) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P1/02, A61P1/04, A61P1/16, A61P1/18